DBVT News and Press, DBV Technologies S.A. From 01/15/21

Gainers: ObsEva (OBSV) +56%, DBV Technologies (DBVT) +44%, Senseonics Holdings (SENS) +39%, Avinger (AVGR) +33%, Bionano Genomics (BNGO) +28%.Losers: Cardiff Oncology (CRDF) -20%, SOS (SOS) -18%, Lexicon Pharmaceuticals (LXRX) -11%,&...

Charah Solutions (CHRA) +105% on being awarded large-scale, 12-Year ash marketing contract.DBV Technologies (DBVT) +57% on FDA response regarding Viaskin Peanut application.ObsEva (OBSV) +43%.Atlantic Power (AT) +41% on being acquired by I Squared Capital.Senseonics Holdings (S...

Trending Penny Stocks To Watch For The End Of The Week As we inch further into 2021, investors continue to focus on penny stocks . But, if this year has shown us anything, it’s that volatility and speculation are both very high. During this week, several factors have been imp...

DBV Technologies (DBVT) rallies as it announced the receipt of written responses from the FDA to questions provided in the Type A meeting request the Co. submitted in October 2020.The Type A meeting request is for Biologics License Application for Viaskin™ Peanut, an investigation...

Gainers: [[OBSV]] +33%. [[DBVT]] +28.1%. [[TUFN]] +21.8%. [[BB]] +17.2%. [[PPIH]] +13.4%.Losers: [[EAF]] -5%. [[MIK]] -4.4%. [[DOGZ]] -3.9%. [[WBAI]] -3.5%. [[LCI]] -3.2%. For further details see: BB, LCI, OBSV and MIK among after-hours movers

Montrouge, France, January 14, 2020 DBV Technologies Provides Update on Investigational Viaskin™ Peanut for Children Ages 4-11 Years DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical compa...

Addex Therapeutics (ADXN) -22% after pricing share offering.Urban One (UONEK) -18%.Urban One (UONE) -17%.Digital Ally (DGLY) -15% after suspends stock offering.Bed Bath & Beyond (BBBY) -14% on Q3 earnings release.SuperCom (SPCB) -12%.DBV Technologies (DBVT)&#...

DBV Technologies (DBVT) has determined that it now qualifies as a U.S. domestic issuer rather than a foreign private issuer in the U.S. As of January 1, the company is subject to SEC and other rules and regulations applicable to U.S. domestic issuers, in addition to French and EU regulations....

Montrouge, France, January 7, 2021 DBV Technologies Announces Change in U.S. Reporting Status and Final Approval of Global Restructuring Process DBV Technologies S.A. (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutic...

TAT Technologies (TATT) +37% after signing strategic agreement with Honeywell.Change Healthcare Inc. (CHNG) +35% as UnitedHealth to acquire the company for $25.75 in cash.DBV Technologies S.A. (DBVT) +19%.Aurora Cannabis (ACB) +17% on possible Georgia 'blue sweep'.HEXO (HEXO) +17%&#...